Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 18, 2019
Principal Executive Office: Boca Raton, FL
Trading Symbol: TXMD (Nasdaq)
This filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) dated December 18, 2019, which may be used in meetings with investors or analysts.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial statement report.
Material Changes
No material changes to financial performance or operations are detailed within the text of this Form 8-K. The filing solely references the distribution of an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation for use in investor relations activities.
Legal Status of Information: The information contained in this report and its exhibits is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation dated December 18, 2019) for specific financial data and strategic outlook, as these details are not in the 8-K text.
- Verify that the presentation has not been superseded by subsequent filings or press releases.
- Confirm the company's current status on the Nasdaq Stock Market under symbol TXMD.